Inventors with similar research interests:
Location History:
- Minato-ku, JP (2008 - 2013)
- Tokyo, JP (2010 - 2014)
- Bunkyo-ku, JP (2011 - 2017)
- Kanagawa, JP (2013 - 2022)
- Kawasaki, JP (2014 - 2023)
Company Filing History:
73 out of 148 
1 out of 37 
Years Active: 2008-2023
Title: Takuya Tsunoda: A Pioneer in Cancer Immunotherapy
Introduction
Takuya Tsunoda is a distinguished inventor and researcher based in Kanagawa, Japan. With an impressive portfolio of 73 patents, Tsunoda has made significant contributions to the field of cancer immunotherapy, focusing on innovative peptide-based vaccines that aim to strengthen the immune response against tumors.
Latest Patents
Tsunoda's latest inventions showcase groundbreaking advancements in cancer treatment. One notable patent involves KOC1-derived epitope peptides, which possess the ability to induce cytotoxic T cells. This invention includes polynucleotides encoding these peptides and methods for presenting them through antigen-presenting cells. The ultimate goal is to treat and prevent cancer, including methods to hinder postoperative recurrence. Another key patent features UBE2T-derived peptides, aimed at creating peptide vaccines that enhance CTL response against cancer. This includes isolated antigen-presenting cells capable of inducing CTLs and the development of pharmaceutical compositions using these peptides as active ingredients.
Career Highlights
Throughout his career, Takuya Tsunoda has been affiliated with notable institutions such as Oncotherapy Science, Incorporated, and Tokushima University. His work has advanced the scientific community's understanding of cancer immunology and has paved the way for effective therapeutic strategies.
Collaborations
Tsunoda has collaborated with esteemed colleagues, including Yusuke Nakamura and Sachiko Yoshimura, both of whom share his commitment to innovation in cancer research. Their joint efforts have further enhanced the development of novel therapeutic approaches that could potentially benefit patients worldwide.
Conclusion
Takuya Tsunoda's contributions to cancer immunotherapy represent a significant leap forward in the battle against cancer. With his extensive patent portfolio and collaborations with leading professionals, Tsunoda is poised to continue influencing the field of medical research, ultimately improving treatment options for cancer patients globally.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.